A heart-rate-reducing medication reduces the risk of heart failure and cardiac fibrosis
Thursday, July 28, 2011 - 13:40
in Health & Medicine
A new study suggest that ivabradine, a heart rate reduction medication, is also effective in reducing the risk of diastolic heart failure (left ventricular insufficiency) and cardiac fibrosis.